Excise duty framework for cannabis products

https://policybase.cma.ca/link/policy13799
Date
2017-12-07
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Non-prescription availability of low-dose codeine products

https://policybase.cma.ca/link/policy13734
Date
2017-11-7
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-45: The Cannabis Act

https://policybase.cma.ca/link/policy13723
Date
2017-08-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA response to patented medicines regulations consultations

https://policybase.cma.ca/link/policy13690
Date
2017-06-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/link/policy13726
Date
2017-05-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13641
Date
2017-04-07
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA submission to the study of Bill C-37

https://policybase.cma.ca/link/policy13617
Date
2017-04-06
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the renewal of Federal Tobacco Control Strategy

https://policybase.cma.ca/link/policy13804
Date
2017-04-05
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Position statement on prescription drug shortages in Canada

https://policybase.cma.ca/link/policy10756
Last Reviewed
2017-03-04
Date
2013-05-25
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Last Reviewed
2017-03-04
Date
2013-05-25
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail